TrialBMC cancer2012

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

David A Palma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.